China Total Current Liabilities vs Deferred Long Term Liab Analysis

600511 Stock   32.56  0.18  0.55%   
China National financial indicator trend analysis is way more than just evaluating China National Medicines prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether China National Medicines is a good investment. Please check the relationship between China National Total Current Liabilities and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Liabilities vs Deferred Long Term Liab

Total Current Liabilities vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of China National Medicines Total Current Liabilities account and Deferred Long Term Liab. At this time, the significance of the direction appears to have very strong relationship.
The correlation between China National's Total Current Liabilities and Deferred Long Term Liab is 0.87. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of China National Medicines, assuming nothing else is changed. The correlation between historical values of China National's Total Current Liabilities and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of China National Medicines are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Total Current Liabilities i.e., China National's Total Current Liabilities and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.87
Relationship DirectionPositive 
Relationship StrengthStrong

Total Current Liabilities

Total Current Liabilities is an item on China National balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of China National Medicines are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.
Most indicators from China National's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into China National Medicines current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
As of January 6, 2025, Selling General Administrative is expected to decline to about 459.3 M. In addition to that, Tax Provision is expected to decline to about 495.7 M
 2022 2023 2024 2025 (projected)
Operating Income2.4B2.5B2.8B3.0B
Total Revenue45.5B49.7B57.2B60.0B

China National fundamental ratios Correlations

0.070.971.00.960.980.960.750.96-0.071.00.70.890.98-0.430.990.870.480.920.93-0.90.910.860.940.910.84
0.070.190.010.19-0.090.130.320.150.880.110.420.18-0.03-0.160.16-0.220.130.30.21-0.380.160.270.17-0.13-0.33
0.970.190.961.00.940.970.851.00.020.970.720.90.96-0.470.970.820.510.890.92-0.910.870.840.960.840.76
1.00.010.960.960.990.960.720.96-0.130.990.670.890.99-0.430.980.890.470.90.92-0.860.910.850.940.920.86
0.960.191.00.960.930.970.850.990.020.960.710.90.96-0.460.970.820.510.880.92-0.90.870.850.960.840.76
0.98-0.090.940.990.930.940.710.94-0.230.970.610.850.99-0.430.960.910.440.860.89-0.820.870.80.910.920.88
0.960.130.970.960.970.940.760.97-0.010.960.750.910.96-0.30.940.880.630.870.91-0.860.880.810.920.850.79
0.750.320.850.720.850.710.760.860.250.770.650.710.72-0.430.80.480.480.710.7-0.830.580.670.770.560.44
0.960.151.00.960.990.940.970.860.020.960.720.910.96-0.430.970.820.550.870.91-0.90.860.850.950.840.76
-0.070.880.02-0.130.02-0.23-0.010.250.02-0.020.350.04-0.180.110.0-0.350.160.150.04-0.26-0.030.160.0-0.25-0.47
1.00.110.970.990.960.970.960.770.96-0.020.730.890.97-0.420.990.840.490.930.93-0.920.90.860.940.890.81
0.70.420.720.670.710.610.750.650.720.350.730.730.63-0.050.720.490.650.820.8-0.790.760.810.780.680.43
0.890.180.90.890.90.850.910.710.910.040.890.730.9-0.240.890.740.690.80.83-0.760.820.770.830.770.74
0.98-0.030.960.990.960.990.960.720.96-0.180.970.630.9-0.430.960.910.470.860.91-0.830.90.830.930.920.87
-0.43-0.16-0.47-0.43-0.46-0.43-0.3-0.43-0.430.11-0.42-0.05-0.24-0.43-0.49-0.250.39-0.46-0.470.51-0.43-0.43-0.49-0.37-0.33
0.990.160.970.980.970.960.940.80.970.00.990.720.890.96-0.490.80.450.940.93-0.930.90.870.950.870.8
0.87-0.220.820.890.820.910.880.480.82-0.350.840.490.740.91-0.250.80.460.70.79-0.630.790.670.80.870.81
0.480.130.510.470.510.440.630.480.550.160.490.650.690.470.390.450.460.340.36-0.360.330.320.380.330.34
0.920.30.890.90.880.860.870.710.870.150.930.820.80.86-0.460.940.70.340.97-0.950.950.950.950.870.69
0.930.210.920.920.920.890.910.70.910.040.930.80.830.91-0.470.930.790.360.97-0.910.980.960.990.930.75
-0.9-0.38-0.91-0.86-0.9-0.82-0.86-0.83-0.9-0.26-0.92-0.79-0.76-0.830.51-0.93-0.63-0.36-0.95-0.91-0.84-0.89-0.91-0.77-0.6
0.910.160.870.910.870.870.880.580.86-0.030.90.760.820.9-0.430.90.790.330.950.98-0.840.940.950.950.79
0.860.270.840.850.850.80.810.670.850.160.860.810.770.83-0.430.870.670.320.950.96-0.890.940.930.880.66
0.940.170.960.940.960.910.920.770.950.00.940.780.830.93-0.490.950.80.380.950.99-0.910.950.930.930.76
0.91-0.130.840.920.840.920.850.560.84-0.250.890.680.770.92-0.370.870.870.330.870.93-0.770.950.880.930.86
0.84-0.330.760.860.760.880.790.440.76-0.470.810.430.740.87-0.330.80.810.340.690.75-0.60.790.660.760.86
Click cells to compare fundamentals

China National Account Relationship Matchups

China National fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets24.9B27.5B29.6B32.5B37.3B39.2B
Other Current Liab1.2B1.5B1.0M1.2M1.4M1.3M
Total Current Liabilities11.2B12.7B12.7B13.9B16.0B16.8B
Total Stockholder Equity11.4B12.8B14.2B15.8B18.1B19.0B
Accounts Payable9.0B10.1B9.9B10.9B12.6B13.2B
Cash6.2B7.3B8.9B10.9B12.6B13.2B
Other Assets242.6M283.9M299.0M345.4M397.2M417.1M
Net Receivables5.4B5.7B5.7B9.0B10.3B10.8B
Inventory3.0B3.5B3.7B4.0B4.6B4.8B
Other Current Assets198.6M280.6M14.5M8.7M10.0M9.5M
Total Liab11.8B13.1B13.7B14.9B17.2B18.0B
Property Plant Equipment628.5M832.7M895.7M845.1M971.8M1.0B
Retained Earnings8.3B9.7B10.5B12.0B13.8B14.5B
Intangible Assets330.4M326.2M330.9M386.1M444.0M466.2M
Other Liab233.2M265.0M313.7M718.4M826.2M867.5M
Net Tangible Assets8.8B10.1B11.0B12.3B14.2B9.2B
Other Stockholder Equity15.9M22.5M27.7M24.9M22.4M25.5M
Deferred Long Term Liab56.8M71.8M90.3M89.6M103.0M68.2M
Total Current Assets22.1B24.5B25.8B28.3B32.5B22.0B
Non Current Assets Total2.8B3.0B3.8B4.2B4.8B3.0B
Non Currrent Assets Other674.8M139.6M686.7M686.0M789.0M828.4M
Non Current Liabilities Total573.8M491.1M1.0B1.0B1.2B1.2B
Non Current Liabilities Other178.1M226.6M215.2M747.1M859.2M902.2M
Net Invested Capital11.9B13.2B14.5B16.0B18.5B13.5B
Short Long Term Debt471.8M428.8M252.1M268.4M241.5M456.0M
Net Working Capital10.9B11.8B13.0B14.4B16.5B12.1B
Property Plant And Equipment Net895.7M845.1M857.9M827.0M744.3M681.4M
Capital Lease Obligations260.1M197.3M182.6M205.1M184.6M161.9M
Property Plant And Equipment Gross1.3B1.4B1.4B827.0M744.3M992.3M

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

Balance Sheet is a snapshot of the financial position of China National Medicines at a specified time, usually calculated after every quarter, six months, or one year. China National Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of China National and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which China currently owns. An asset can also be divided into two categories, current and non-current.